v3.25.2
Loss Per Common Share (Tables)
 6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):
For the Three Months Ended June 30,For the Six Months Ended June 30,
2025202420252024
Income (loss) before preferred dividends and accretion of Series A Preferred Stock$(19,897)$1,596 $(84,515)$(15,684)
Dividends and accretion of Series A Preferred Stock(31,193)(7,979)(38,825)(15,924)
Net loss attributable to common shareholders of Evolent Health, Inc.$(51,090)$(6,383)$(123,340)$(31,608)
Weighted-average common shares outstanding - basic and diluted115,882 114,688 115,600 114,415 
Loss per common share
Basic and diluted$(0.44)$(0.06)$(1.07)$(0.28)
Schedule of Antidilutive Securities Excluded From Computation of Earnings Per Share
Anti-dilutive shares excluded from the calculation of weighted-average common shares presented above are presented below (in thousands):
For the Three Months Ended June 30,For the Six Months Ended June 30,
2025202420252024
Restricted stock units (“RSUs”), performance-based RSUs (“PSUs”) and leveraged stock units (“LSUs”)669 533 665 854 
Stock options— 289 — 351 
Series A Preferred Stock4,375 4,375 4,375 4,375 
Convertible senior notes15,752 20,252 15,752 20,252 
Total20,796 25,449 20,792 25,832